Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Blinklab Limited ( (AU:BB1) ) has provided an announcement.
BlinkLab Limited has appointed Dr Hendrikus Johannes Boele as a director effective 17 December 2025. According to the initial director’s interest notice lodged with the ASX, Dr Boele holds no BlinkLab securities in his own name but, through his role as sole director and shareholder of Cason Holding BV, has an indirect interest in 35,594 ordinary shares, 6,747,739 escrowed ordinary shares, 7,500,000 escrowed unlisted options exercisable at $0.25 expiring in September 2026, and 750,000 escrowed performance rights, underscoring a significant, performance‑linked alignment with shareholder interests.
More about Blinklab Limited
Average Trading Volume: 358,097
Technical Sentiment Signal: Buy
Current Market Cap: A$109.5M
See more data about BB1 stock on TipRanks’ Stock Analysis page.